- Home
- NTHI vs IAF Comparison
NTHI vs IAF Comparison
Compare NTHI & IAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTHI
- IAF
- Stock Information
- Founded
- NTHI 2008
- IAF 1985
- Country
- NTHI United States
- IAF United States
- Employees
- NTHI N/A
- IAF N/A
- Industry
- NTHI Biotechnology: Pharmaceutical Preparations
- IAF Finance/Investors Services
- Sector
- NTHI Health Care
- IAF Finance
- Exchange
- NTHI Nasdaq
- IAF Nasdaq
- Market Cap
- NTHI 110.9M
- IAF 123.6M
- IPO Year
- NTHI N/A
- IAF N/A
- Fundamental
- Price
- NTHI $5.10
- IAF $4.46
- Analyst Decision
- NTHI
- IAF
- Analyst Count
- NTHI 0
- IAF 0
- Target Price
- NTHI N/A
- IAF N/A
- AVG Volume (30 Days)
- NTHI 284.4K
- IAF 90.4K
- Earning Date
- NTHI 01-01-0001
- IAF 01-01-0001
- Dividend Yield
- NTHI N/A
- IAF 11.44%
- EPS Growth
- NTHI N/A
- IAF N/A
- EPS
- NTHI N/A
- IAF N/A
- Revenue
- NTHI $79,990.00
- IAF N/A
- Revenue This Year
- NTHI N/A
- IAF N/A
- Revenue Next Year
- NTHI N/A
- IAF N/A
- P/E Ratio
- NTHI N/A
- IAF N/A
- Revenue Growth
- NTHI 13.52
- IAF N/A
- 52 Week Low
- NTHI $3.20
- IAF $3.60
- 52 Week High
- NTHI $25.00
- IAF $4.59
- Technical
- Relative Strength Index (RSI)
- NTHI N/A
- IAF 49.66
- Support Level
- NTHI N/A
- IAF $4.47
- Resistance Level
- NTHI N/A
- IAF $4.54
- Average True Range (ATR)
- NTHI 0.00
- IAF 0.05
- MACD
- NTHI 0.00
- IAF -0.01
- Stochastic Oscillator
- NTHI 0.00
- IAF 33.33
About NTHI NeOnc Technologies Holdings Inc. Common Stock
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration ("FDA").
About IAF abrdn Australia Equity Fund Inc.
Aberdeen Australia Equity Fund Inc is a non-diversified closed-end investment management company. With a core focus on long-term capital appreciation, it invests predominantly in equity securities listed on the Australian Stock Exchange. Its secondary objective is current income, which it expects to derive from dividends and interest on Australian corporate and governmental securities. Its investment portfolio comprises diversified sectors that include Financials, Health Care, Materials, Information Technology, Real Estate, and other sectors.